132 related articles for article (PubMed ID: 17901069)
41. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.
Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA
Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723
[TBL] [Abstract][Full Text] [Related]
42. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
[TBL] [Abstract][Full Text] [Related]
43. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
44. Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.
Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Sioulis A; Balaskas E; Zebekakis P; Sarafidis PA
Kidney Blood Press Res; 2018; 43(3):744-754. PubMed ID: 29794429
[TBL] [Abstract][Full Text] [Related]
45. The diagnostic efficacy of urinary TGF-beta1 and VEGF in bladder cancer: comparison with voided urine cytology.
Eissa S; Salem AM; Zohny SF; Hegazy MG
Cancer Biomark; 2007; 3(6):275-85. PubMed ID: 18048965
[TBL] [Abstract][Full Text] [Related]
46. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
[TBL] [Abstract][Full Text] [Related]
47. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
48. Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection.
Hussein A; Askar E; Elsaeid M; Schaefer F
Nephrol Dial Transplant; 2010 Mar; 25(3):779-85. PubMed ID: 19861314
[TBL] [Abstract][Full Text] [Related]
49. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
50. Endothelial cell-selective adhesion molecule in diabetic nephropathy.
Kacso IM; Kacso G
Eur J Clin Invest; 2012 Nov; 42(11):1227-34. PubMed ID: 22957687
[TBL] [Abstract][Full Text] [Related]
51. Urinary active transforming growth factor β in feline chronic kidney disease.
Lawson JS; Syme HM; Wheeler-Jones CP; Elliott J
Vet J; 2016 Aug; 214():1-6. PubMed ID: 27387717
[TBL] [Abstract][Full Text] [Related]
52. URINARY EXCRETION OF TGF-Β1 AND VEGF IN CHILDREN WITH VESICOURETERAL REFLUX.
Makieieva NI; Morozova OO; Iarova KK; Pryima YS; Golovachova VO; Vygivska LA
Wiad Lek; 2020; 73(11):2411-2415. PubMed ID: 33454675
[TBL] [Abstract][Full Text] [Related]
53. Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.
Engels EA; Jennings L; Kemp TJ; Chaturvedi AK; Pinto LA; Pfeiffer RM; Trotter JF; Acker M; Onaca N; Klintmalm GB
Cancer Med; 2015 Aug; 4(8):1252-7. PubMed ID: 25919050
[TBL] [Abstract][Full Text] [Related]
54. Transforming growth factor beta 1 in children with systemic lupus erythematosus: a possible relation with clinical presentation of lupus nephritis.
Hammad AM; Youssef HM; El-Arman MM
Lupus; 2006; 15(9):608-12. PubMed ID: 17080918
[TBL] [Abstract][Full Text] [Related]
55. Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria.
Vlachojannis JG; Tsakas S; Petropoulou C; Goumenos DS; Alexandri S
Clin Nephrol; 2002 Nov; 58(5):337-43. PubMed ID: 12425483
[TBL] [Abstract][Full Text] [Related]
56. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease.
Habenicht LM; Webb TL; Clauss LA; Dow SW; Quimby JM
J Feline Med Surg; 2013 Feb; 15(2):99-104. PubMed ID: 22989558
[TBL] [Abstract][Full Text] [Related]
57. Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney.
Wasilewska A; Zoch-Zwierz W; Taranta-Janusz K
Pediatr Nephrol; 2009 Apr; 24(4):753-9. PubMed ID: 19048302
[TBL] [Abstract][Full Text] [Related]
58. [Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression].
Shvetsov MY; Zheng A; Kozlovskaya LV; Serova AG; Travkina EV; Mukhin NA
Ter Arkh; 2015; 87(6):75-82. PubMed ID: 26281200
[TBL] [Abstract][Full Text] [Related]
59. Urinary endothelin-1 in children with glomerulonephritis.
Tsau YK; Chen CH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1998; 39(2):86-8. PubMed ID: 9599895
[TBL] [Abstract][Full Text] [Related]
60. The relationship between obesity and transforming growth factor beta on renal damage in essential hypertension.
Torun D; Ozelsancak R; Turan I; Micozkadioglu H; Sezer S; Ozdemir FN
Int Heart J; 2007 Nov; 48(6):733-41. PubMed ID: 18160765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
